The government's efforts to elevate the standards of
healthcare facilities have made a significant contribution to the
development of the industry. Along with technological advancements,
the speed of treatment has been enhanced due to better healthcare
infrastructure and facilities.
WILMINGTON, Del., July 17, 2024 /PRNewswire/ -- With the help of
several key forces influencing the growth of the sector, the CNS
therapeutic market will encompass a near-to-impressive CAGR
of 7.7% through the forecasted period.
The progress of the competitive landscape will help the market
valuation reach USD 231.8
billion by 2034. The last recorded size of the industry
was USD 102.4 billion in
2023.
The likelihood of various neurological disorders is growing with
the rising senior population across the world. Along with this,
many psychological disorders are observed to have increased with
the growing geriatric population.
The growing levels of stress, anxiety, and other related factors
are fueling the increasing number of psychologically challenged
patients. Due to this, patients seeking medical attention
increased, driving the global CNS therapeutic market.
Get a PDF Sample of this Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=74787
The growing cases of brain damage and brain disorders surge the
demand for suitable treatment and therapies. As such diseases are
closely related to central nervous systems, the demand for
the market will likely increase.
With the introduction of new drugs and therapies in the sector,
the competitive landscape is constantly developing. Due to this,
the scope for new entrants is continuously increasing, helping
organizations explore new market openings.
Technological innovation is playing a vital role in developing
new drugs. This has been helping key players to constantly
introduce new treatments, therapies, and medicines for patients,
driving the market.
The development of the healthcare sector is another contributing
factor to the development of the competitive landscape. Due to the
growth in the industry, new prospects are generated for the CNS
therapeutic market, leveraging the growth rate of the industry.
With government support for the exploration of new avenues in
the field, key players explore new market openings, diversifying
the competitive landscape. As a result, this is another crucial
driving force for the ecosystem.
Central Nervous System Therapeutics Market Report
Scope:
Report
Coverage
|
Details
|
Forecast
Period
|
2024-2034
|
Base
Year
|
2020-2022
|
Size in 2023
|
US$ 102.4 Bn
|
Forecast (Value) in
2034
|
US$ 231.8 Bn
|
Growth Rate
(CAGR)
|
7.7 %
|
No. of
Pages
|
174
Pages
|
Segments
covered
|
By Drug Class, By
Disease Type, By Distribution, By Region, By End-user
|
Key Findings from the Market Report
- The competitive landscape can be segmented based on various
categories that contribute to the growth of the CNS therapeutic
market. Based on the drug class segment, analgesics have great
importance. Neurological surgeries are highly painful, and hence,
to manage the pains of patients, analgesics are used.
- Based on the disease type, neurodegenerative disorders have
been seen to have increased recently. As a result, more prospects
are created by the segment for leading players to explore a wider
market landscape.
- With the growing stress levels, anxiety issues, and various
other related issues, the mental health segment will likely create
more prospects for the industry.
- A hospital is the category based on the distribution channel
that creates the highest prospects for the CNS therapeutic market
due to the growing number of complex surgeries.
Regional Profile
- The bolstered healthcare infrastructure in North America creates many lucrative growth
prospects for leading players in the CNS therapeutic market.
- With the growing number of mental health disorders in
Europe, more emphasis will be
placed on bolstering the healthcare systems dedicated to addressing
the issue.
- Asia-Pacific projects a
growing geriatric population, which will likely drive the market,
creating several opportunities.
Unlock Growth Potential in Your Industry! Download PDF Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=74787
Competitive Landscape
With the presence of several large-scale organizations, the
competitive space of the industry is cluttered. Product launch is a
key mode of expansion adopted by such companies.
- Biogen is a key player in producing a wide range of medicines,
including Aduhelm, Avonex, Gazyva, and Fampyra.
- Otsuka Pharmaceutical Co., Ltd. is another organization working
in different sectors. It produces EQUELLE for women, BeanStalk for
infants, and many other products.
- Dulaglutide, Insulin Lispro, and insulin delivery medical
devices are some key products of Eli Lilly and Company.
Key Players
- Biogen
- Otsuka Pharmaceutical Co. Ltd.
- Eli Lilly and Company
- Merck & Co. Inc.
- AstraZeneca
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Takeda Pharmaceuticals
- Johnson & Johnson Services Inc.
Key Developments in the Central Nervous System Therapeutics
Market
- In May 2024, Biogen acquired
Human Immunology Biosciences. This move helped the organization
expand its portfolio.
- In May 2024, Otsuka
Pharmaceutical Co. Ltd. launched a new basic skincare line to cater
to epidermal imbalance.
Market Segmentation
Drug Class
- Analgesics
- Anti-Cholinergic Agents
- Anticonvulsants
- Sedatives and Hypnotics
- Anti-Depressants
- Others (Antipsychotics, etc.)
Disease Type
- Neurodegenerative Disorders
- Alzheimer's disease
- Parkinson's disease
- Huntington's disease
- Amyotrophic Lateral Sclerosis
- Others (Multiple Sclerosis, etc.)
- Mental Health
- Anxiety Disorders
- Epilepsy
- Psychotic Disorders
- Others (Mood Disorders, etc.)
- Neurovascular Diseases
- CNS Trauma
- CNS Cancer
- Others (Infectious Disorders, etc.)
Distribution Channel
- Hospitals
- Biopharmaceutical Companies
- Research Organizations and Academic Institutes
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Buy this Premium Research Report to Decode Industry Data:
https://www.transparencymarketresearch.com/checkout.php?rep_id=74787<ype=S
More Trending Reports by Transparency Market Research
–
- Diagnostic Dermatology Equipment Market - The
global diagnostic dermatology equipment market is projected to
advance at a CAGR of 12.8% from 2024 to 2034
- Digital Biomarkers Market - The global digital
biomarkers market is projected to expand at a CAGR of 31.4%
during the forecast period from 2024 to 2034
- Cryotherapy Market - Rising Prevalence of
Dermatological Disorders and Cancer Drives Demand for Cryo Cooling
Therapy, Boosting the Cryotherapy Market
In About Transparency Market Research
Transparency Market Research, a global market research
company registered at Wilmington, Delaware, United States, provides custom research and
consulting services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insights
for thousands of decision makers. Our experienced team of Analysts,
Researchers, and Consultants use proprietary data sources and
various tools & techniques to gather and analyses
information.
Our data repository is continuously updated and revised by a
team of research experts, so that it always reflects the latest
trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary
and secondary research techniques in developing distinctive data
sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE
HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware
19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter|
Blog | YouTube
Logo:
https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/future-of-central-nervous-system-therapeutics-market-worth-usd-231-8-billion-by-2034--growing-at-7-7-cagr-transparency-market-research-inc-302198490.html